EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Trh analog with carboxyl terminal thioamide group rapid degradation by plasma and its biological effects


Endocrinologia Experimentalis 19(4): 213-219
Trh analog with carboxyl terminal thioamide group rapid degradation by plasma and its biological effects
L-pyroglutamyl-L-histidyl-L-proline thioamide - ([Prot3]TRH), a new TRH analogue, has been previously found to have the same binding affinity to adenopituitary receptors as well as TSH and .alpha.-MSH releasing activities as native TRH. In this paper we report also the same time course of TSH response after i.p. injection of this compound (10 .mu.g kg-1) to rats. Binding affinity to specific receptors in rat amygdala, cortex (frontal lobes), hypothalamus, striatum (order according to decreasing affinity) of both peptides was also similar. In contrast to TRH, however, [Prot3]TRH in doses 0.5 and 5 mg kg-1 i.p. did not affect sleeping time and breathing frequency in the rats during barbiturate anaesthesia. Surprisingly, human plasma degraded the new analogue much faster (T1/2 8.5 min) than native TRH (T1/2 30 min). [Prot3]TRH was also degraded faster in plasma of adult rats. Plasma of 6-day-old rat pups failed to degraded both peptides. It was concluded that the substitution of proline amide, for proline thioamide group in TRH molecule did not change binding affinity to receptors to the central nervous system, but decreased biological effectiveness in CNS and substantially decreased the resistance to degradation in human and rat plasma.

(PDF 0-2 workdays service: $29.90)

Accession: 006839665



Related references

TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects. Endocrinologia Experimentalis 19(4): 213-219, 1985

Synthesis and some biological properties of the hexapeptide analog of substance p with a carboxyl terminal thioamide group. Polish Journal of Pharmacology & Pharmacy 42(5): 483-490, 1990

Solid phase synthesis of a ghrp analog containing carboxyl terminal thioamide group. Biochemical & Biophysical Research Communications 150(3): 1017-1020, 1988

Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group. Polish Journal of Pharmacology and Pharmacy 42(5): 483-490, 1990

Trh analog with carboxyl terminal thioamide group synthesis receptor binding tsh releasing activity and alpha msh releasing activity. Experientia (Basel) 41(12): 1576-1577, 1985

Solid phase synthesis of a GHRP analog containing C-terminal thioamide group. Biochemical and Biophysical Research Communications 150(3): 1017-1020, 1988

Contracting activity of carboxyl terminal fragments and a carboxyl terminal hexa peptide analog of substance p on nonstimulated and electrically stimulated isolated guinea pig ileum. General Pharmacology 12(2): 119-121, 1981

Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation. Science 243(4897): 1493-1495, 1989

Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues. Journal of Biological Chemistry 287(34): 28362-28377, 2012

Synthesis and biological properties of the 5 n 5 di methyl glutamine analog of the carboxyl terminal hepta peptide of substance p active site studies. Febs Letters 108(1): 45-46, 1979